Buhlmann Laboratories AG (Buhlmann) develops and manufacturers in vitro diagnostic products. The company's products include cap collection set and quantum blue diagnostic test kit. It markets its products under the brands including Ibdoc, CalApp, Buhlmann fCAL, Calex, Cast, Quantum Blue, GanglioCombi. These products and services are used in various industries for diagnostic work and research activities, particularly in the areas of gastroenterology, autoimmunity, cellular allergy, and neuroimmunology. The company operates in Switzerland and Germany. Buhlmann is headquartered in Arlesheim, Switzerland.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Buhlmann Laboratories AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Buhlmann Laboratories AG Company Overview
- Buhlmann Laboratories AG Company Snapshot
- Buhlmann Laboratories AG Pipeline Products and Ongoing Clinical Trials Overview
- Buhlmann Laboratories AG - Pipeline Analysis Overview
- Buhlmann Laboratories AG - Key Facts
- Buhlmann Laboratories AG - Major Products and Services
- Buhlmann Laboratories AG Pipeline Products by Development Stage
- Buhlmann Laboratories AG Pipeline Products Overview
- IDH 1/2 Mutation Detection Test
- IDH 1/2 Mutation Detection Test Product Overview
- NGS Targeted Hotspot Panel 16 Kit
- NGS Targeted Hotspot Panel 16 Kit Product Overview
- PureNA Cell-Free DNA Isolation Kit
- PureNA Cell-Free DNA Isolation Kit Product Overview
- Quantum Blue SARS-CoV-2 RBD Plus Assay
- Quantum Blue SARS-CoV-2 RBD Plus Assay Product Overview
- Buhlmann Laboratories AG - Key Competitors
- Buhlmann Laboratories AG - Key Employees
- Buhlmann Laboratories AG - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Buhlmann Laboratories AG, Recent Developments
- Feb 17, 2024: Buhlmann Laboratories Additional Receives 510(K) Clearance For BUHLMANN fCAL Turbo And CALEX Cap
- Jul 16, 2019: One year using IBDoc, a patients view
- Nov 23, 2018: Otago invention helps patients manage Inflammatory Bowel Disease
- Jun 12, 2018: BUHLMANN Laboratories Receives FDA Clearance for its fCAL ELISA Calprotectin Test
- Dec 15, 2017: Irish user report: Cork is bringing Calprotectin testing in-house on Abbott Architect
- Sep 28, 2017: Buhlmann Laboratories: Health Care Business Award for IBDoc
- Sep 06, 2017: ePAT signs core strategic agreement with Dementia Support Australia (DSA)
- Dec 15, 2016: BUHLMANN announces new Microsite for Kinase Inhibition Assay
- Oct 05, 2016: First Publication using BUHLMANN's Quantum Blue Infliximab Trough Level Assay
- Jan 14, 2016: Buhlmann Laboratories Opens North American Affiliate
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Buhlmann Laboratories AG Pipeline Products and Ongoing Clinical Trials Overview
- Buhlmann Laboratories AG Pipeline Products by Equipment Type
- Buhlmann Laboratories AG Pipeline Products by Indication
- Buhlmann Laboratories AG, Key Facts
- Buhlmann Laboratories AG, Major Products and Services
- Buhlmann Laboratories AG Number of Pipeline Products by Development Stage
- Buhlmann Laboratories AG Pipeline Products Summary by Development Stage
- IDH 1/2 Mutation Detection Test - Product Status
- IDH 1/2 Mutation Detection Test - Product Description
- NGS Targeted Hotspot Panel 16 Kit - Product Status
- NGS Targeted Hotspot Panel 16 Kit - Product Description
- PureNA Cell-Free DNA Isolation Kit - Product Status
- PureNA Cell-Free DNA Isolation Kit - Product Description
- Quantum Blue SARS-CoV-2 RBD Plus Assay - Product Status
- Quantum Blue SARS-CoV-2 RBD Plus Assay - Product Description
- Buhlmann Laboratories AG, Key Employees
- Buhlmann Laboratories AG, Subsidiaries
- Glossary
- Buhlmann Laboratories AG Pipeline Products by Equipment Type
- Buhlmann Laboratories AG Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- CeQur SA
- Aleva Neurotherapeutics SA
- Acrostak (Schweiz) AG
